≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Specific developmental disorder of motor function

DOID Endpoint Browser

F5_MOTOR

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F82
  • Hospital discharge: ICD-9 — 3154
  • Cause of death: ICD-10 — F82
  • Cause of death: ICD-9 — 3154

2 out of 7 registries used, show all original rules.

612

4. Check minimum number of events

None

612

5. Include endpoints

None

612

6. Filter based on genotype QC (FinnGen only)

612

Control definitions (FinnGen only)

Control exclude
F5_PSYCHDEV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F80-F89
Name in latin
Perturbatio specifica progressus functionis motoricae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 612 255 357
Unadjusted period prevalence (%) 0.13 0.09 0.16
Median age at first event (years) 6.12 6.05 6.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
552
Matched controls
5419
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F82
ICD-10 Finland
Specific developmental disorder of motor function
16060.3
323.0
517
6
F83
ICD-10 Finland
Mixed specific developmental disorders
+∞
158.2
145
*
F80.1
ICD-10 Finland
Expressive language disorder
250.9
103.8
104
5
XA800
NOMESCO Finland
Neuropsychological investigation
18.7
93.8
151
107
R62.0
ICD-10 Finland
Delayed milestone
21.8
87.3
132
77
F80.2
ICD-10 Finland
Receptive language disorder
206.0
71.5
73
*
Z2445
NOMESCO Finland
Psychologist
7.8
67.7
176
306
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
10.0
65.7
142
181
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
20.1
64.9
100
59
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
357.9
64.4
64
*
Z3226
NOMESCO Finland
Physiotherapist
5.4
63.6
243
689
R4120
NOMESCO Finland
Occupational therapy
13.5
63.5
116
105
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.9
57.9
164
314
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
187.5
50.5
52
*
R4110
NOMESCO Finland
Physiotherapy
4.4
47.9
218
697
Z2446
NOMESCO Finland
Social worker
4.7
42.5
172
480
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.9
41.2
128
265
Z2221
NOMESCO Finland
Medical doctor
3.9
41.1
221
798
ZXE10
NOMESCO Finland
More than one and less than three hours
3.6
38.9
235
924
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
38.8
37
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.2
38.3
173
530
Z3231
NOMESCO Finland
Registered nurse
3.2
35.5
281
1328
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
35.3
177
589
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
97.2
33.9
37
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.2
33.1
146
430
RT150
NOMESCO Finland
NA
22.3
32.9
48
23
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
94.4
32.9
36
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.7
32.4
88
150
F81.0
ICD-10 Finland
Specific reading disorder
73.1
31.0
35
5
ZXD10
NOMESCO Finland
Scheduled procedure
3.0
30.8
258
1234
RL140
NOMESCO Finland
NA
25.3
30.7
43
18
Z50.5
ICD-10 Finland
Speech therapy
6.8
30.0
79
129
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
59.1
29.2
34
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
28.5
194
795
RT160
NOMESCO Finland
NA
22.8
28.4
41
19
Z3229
NOMESCO Finland
Other healthcare associate professional
4.4
28.3
114
304
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
57.3
28.2
33
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.6
27.7
104
258
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.5
27.5
153
539
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.4
27.5
76
132
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
139.1
25.6
27
*
N06BA04
ATC
methylphenidate; oral
5.2
25.4
84
181
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.4
25.2
100
261
ZY010
NOMESCO Finland
Hospital outpatient
3.9
24.5
110
322
R1260
NOMESCO Finland
Evaluation of communicative skills
18.4
24.0
37
21
ZXE20
NOMESCO Finland
More than three and less than five hours
3.9
23.9
108
317
RL130
NOMESCO Finland
NA
17.6
23.6
37
22
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.7
23.5
86
206
602
Kela drug reimbursment
Children's severe malnutrition
7.0
23.5
60
93
R4130
NOMESCO Finland
Speech therapy
11.1
23.5
45
43
ZXE00
NOMESCO Finland
One hour or less
2.5
23.4
266
1451
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
6.2
23.3
65
114
P07.2
ICD-10 Finland
Extreme immaturity
66.8
22.8
26
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
6.3
22.6
62
106
N05AX08
ATC
risperidone; systemic
5.4
22.4
70
141
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.3
21.7
69
142
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.1
21.6
90
244
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.7
21.3
63
119
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
21.1
87
234
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.7
19.9
93
279
F88
ICD-10 Finland
Other disorders of psychological development
75.0
19.7
22
*
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
19.6
127
483
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
15.1
19.4
32
22
RF120
NOMESCO Finland
NA
23.1
19.0
27
12
F84.5
ICD-10 Finland
Asperger syndrome
35.1
18.9
24
7
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
35.1
18.9
24
7
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.1
18.7
77
206
N05AH03
ATC
olanzapine; systemic
4.7
18.7
66
152
R1250
NOMESCO Finland
Evaluation of functional capability
15.5
18.4
30
20
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.8
18.3
82
237
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
17.9
117
448
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.6
17.9
65
154
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.0
17.3
57
122
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.0
17.2
43
65
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
13.0
16.6
29
23
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
28.0
16.5
22
8
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
18.3
16.4
25
14
N03AG01
ATC
valproic acid; systemic, rectal
4.5
16.2
59
140
R5599
NOMESCO Finland
Other rehabilitation service
7.0
15.8
39
58
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.6
15.6
73
218
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.7
15.5
54
123
N05AH04
ATC
quetiapine; oral
2.7
15.3
114
470
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
15.0
109
440
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.0
15.0
37
55
RS222
NOMESCO Finland
NA
8.7
15.0
32
38
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
14.9
132
599
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
14.8
189
1031
Z31.5
ICD-10 Finland
Genetic counselling
3.7
14.7
67
196
N03AX14
ATC
levetiracetam; systemic
6.8
14.7
37
57
N05AX12
ATC
aripiprazole; systemic
4.1
14.4
57
147
H52.2
ICD-10 Finland
Astigmatism
5.2
14.4
45
91
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.7
14.1
63
181
ZXA00
NOMESCO Finland
Right side
2.8
14.0
99
395
XX4AW
NOMESCO Finland
NA
6.0
13.8
38
66
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.0
13.7
44
92
H01AC01
ATC
somatropin; parenteral
5.0
13.7
44
92
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
13.5
173
938
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
26.0
13.3
18
7
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
14.0
13.2
22
16
H50.31
ICD-10 Finland
Intermittent exotropia
6.9
13.0
32
48
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
7.5
12.9
30
41
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
12.8
100
421
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
12.7
85
327
F20.9
ICD-10 Finland
Schizophrenia, unspecified
10.7
12.7
24
23
ZXA05
NOMESCO Finland
Left side
2.8
12.5
84
324
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
12.5
12
*
RT490
NOMESCO Finland
NA
20.2
12.4
18
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
12.3
125
604
N05CD08
ATC
midazolam; nasal, systemic
5.1
12.1
38
78
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
8.3
12.0
26
32
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.8
12.0
52
146
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.5
11.9
35
66
WX882
NOMESCO Finland
High dependency care
2.8
11.9
80
309
ZYC01
NOMESCO Finland
Remote contact by phone
3.7
11.8
53
153
H50.30
ICD-10 Finland
Intermittent esotropy
6.8
11.7
29
44
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.7
11.7
52
149
L02AE02
ATC
leuprorelin; implant, parenteral
11.2
11.5
21
19
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
11.4
11
*
F89
ICD-10 Finland
Unspecified disorder of psychological development
120.2
11.4
12
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
6.2
11.3
30
50
ZXD20
NOMESCO Finland
Day surgery
2.9
11.3
70
256
RF420
NOMESCO Finland
NA
15.2
11.3
18
12
H35.1
ICD-10 Finland
Retinopathy of prematurity
35.2
11.2
14
*
183
Kela drug reimbursment
Lamotrigin and topiramate
9.0
11.2
23
26
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
20.2
11.1
16
8
FM2CE
NOMESCO Finland
NA
2.9
11.0
68
249
RD210
NOMESCO Finland
NA
3.2
10.9
58
191
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
10.9
75
294
A28
ICPC
Limited function/disability NOS
3.5
10.8
50
148
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.8
10.7
35
75
WX730
NOMESCO Finland
Conventional respirator
9.7
10.7
21
22
RT422
NOMESCO Finland
NA
60.1
10.6
12
*
N05AH02
ATC
clozapine; systemic
6.6
10.5
26
40
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.4
10.4
24
33
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.3
10.4
52
164
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
10.3
47
138
RS220
NOMESCO Finland
NA
5.6
10.2
29
53
SPAT1229
SPAT
Assessment of need for aid
7.2
10.2
24
34
ZXD05
NOMESCO Finland
Urgent procedure
2.0
10.1
141
777
N05AA02
ATC
levomepromazine; systemic
7.0
10.0
24
35
RS211
NOMESCO Finland
NA
7.0
10.0
24
35
N03AX09
ATC
lamotrigine; oral
3.7
9.8
43
122
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
9.8
47
144
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
20.1
9.7
14
7
WX722
NOMESCO Finland
PEEP
4.9
9.7
31
65
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.9
9.7
31
65
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.8
9.7
41
113
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
6.6
9.7
24
37
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.6
9.7
24
37
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
9.7
63
237
N05BA09
ATC
clobazam; oral
6.2
9.6
25
41
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
9.6
181
1114
ZXA10
NOMESCO Finland
Bilateral
2.2
9.6
102
499
R5140
NOMESCO Finland
Monitoring the use of the aid
5.8
9.5
26
46
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.1
9.4
51
171
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.8
9.4
61
228
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
99.9
9.4
10
*
SPAT1234
SPAT
Support of social functional capacity
6.3
9.3
24
39
F84.0
ICD-10 Finland
Childhood autism
+∞
9.3
9
*
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
13.7
9.1
15
11
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.1
9.1
51
173
K03.66
ICD-10 Finland
Tooth plaque
2.2
9.1
101
505
RF210
NOMESCO Finland
NA
6.8
9.1
22
33
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
36.7
9.0
11
*
C03CA01
ATC
furosemide; systemic
4.0
8.9
35
91
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
18.6
8.9
13
7
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
24.0
8.9
12
5
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
8.8
77
343
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.9
8.8
55
202
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.9
8.8
21
31
R11
ICD-10 Finland
Nausea and vomiting
2.5
8.7
70
296
H52.0
ICD-10 Finland
Hypermetropia
3.6
8.6
38
110
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
8.5
29
66
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
16.3
8.5
13
8
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
5.2
8.4
25
49
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
20.0
8.4
12
6
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
20.0
8.4
12
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
8.4
52
189
101
Kela drug reimbursment
Anterior pituitary hypofunction
4.8
8.4
27
58
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
89.7
8.4
9
*
F81.1
ICD-10 Finland
Specific spelling disorder
89.7
8.4
9
*
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
4.3
8.4
30
72
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
+∞
8.3
8
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.4
8.3
29
68
P24
ICPC
Specific learning problem
3.7
8.2
35
98
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
9.5
8.2
16
17
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
7.1
8.2
19
27
RS312
NOMESCO Finland
NA
14.5
8.1
13
9
RT130
NOMESCO Finland
NA
14.5
8.1
13
9
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
8.1
61
250
K07.24
ICD-10 Finland
Open bite
3.7
8.1
34
94
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
33.3
8.0
10
*
RT420
NOMESCO Finland
NA
33.3
8.0
10
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.2
8.0
17
21
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
8.2
8.0
17
21
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
8.2
8.0
17
21
BF20A
NOMESCO Finland
NA
17.2
8.0
12
7
N05BA01
ATC
diazepam; systemic, rectal
3.0
8.0
46
161
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
7.9
33
91
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.9
7.8
46
165
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.4
7.7
15
16
RS231
NOMESCO Finland
NA
44.8
7.7
9
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
15.0
7.7
12
8
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
5.6
7.6
21
38
XCK00
NOMESCO Finland
Perimetry
5.6
7.6
21
38
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.2
7.6
27
65
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.0
7.5
41
139
RS311
NOMESCO Finland
NA
18.3
7.5
11
6
WX002
NOMESCO Finland
Sedation and analgesia
2.3
7.5
68
306
P85
ICPC
Mental retardation
8.1
7.5
16
20
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.6
7.5
32
90
N28
ICPC
Limited function/disability (N)
11.8
7.5
13
11
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
7.5
90
464
RS120
NOMESCO Finland
NA
8.9
7.5
15
17
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.5
7.5
33
96
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.8
7.4
47
175
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.5
7.4
18
28
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.3
7.3
35
108
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.3
7.3
21
40
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
4.8
7.3
23
49
IGP01
NOMESCO Finland
Psychiatric family contact
3.2
7.3
37
120
AA1AD
NOMESCO Finland
CT of head and brain
2.7
7.3
50
196
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
7.3
7
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
7.3
7
*
RT121
NOMESCO Finland
NA
+∞
7.3
7
*
E34.31
ICD-10 Finland
Short stature, prenatal disorder
6.9
7.2
17
25
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
5.0
7.2
22
45
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
6.3
7.2
18
29
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
15.7
7.2
11
7
R27.0
ICD-10 Finland
Ataxia, unspecified
29.9
7.1
9
*
RF430
NOMESCO Finland
NA
20.0
7.1
10
5
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
7.0
108
615
C03DA01
ATC
spironolactone; oral
3.9
6.9
27
71
ZX199
NOMESCO Finland
Other rote
6.3
6.9
17
27
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
6.3
6.9
17
27
ZX108
NOMESCO Finland
Inhalation
5.5
6.9
19
35
N88
ICPC
Epilepsy
7.5
6.8
15
20
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
7.5
6.8
15
20
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
13.7
6.8
11
8
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
6.8
101
564
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
6.7
130
795
E22.80
ICD-10 Finland
Central precocious puberty
10.9
6.7
12
11
SPAT1262
SPAT
Handing over of treatment supplies
2.5
6.7
50
205
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
39.8
6.7
8
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
6.7
30
89
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
6.7
47
188
Q75.3
ICD-10 Finland
Macrocephaly
22.4
6.6
9
*
301
Kela drug reimbursment
Growth hormone
4.9
6.6
20
41
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
4.2
6.6
23
55
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
5.5
6.6
18
33
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.6
6.5
28
80
XG413
NOMESCO Finland
Spirometry with oscillometry
3.6
6.5
28
80
RT190
NOMESCO Finland
NA
12.2
6.5
11
9
H47.2
ICD-10 Finland
Optic atrophy
12.2
6.5
11
9
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
6.5
42
159
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
6.5
122
740
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
8.7
6.5
13
15
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
8.7
6.5
13
15
TJD20
NOMESCO Finland
Change of gastrostomy tube
6.8
6.5
15
22
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
6.4
91
498
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
6.4
48
198
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
6.4
230
1676
R06.5
ICD-10 Finland
Mouth breathing
2.4
6.3
53
231
WX704
NOMESCO Finland
Intubation
3.0
6.3
36
125
DFF00
NOMESCO Finland
Pure tone audiometry
3.1
6.3
33
110
G47.3
ICD-10 Finland
Sleep apnoea
2.8
6.3
40
148
P07.3
ICD-10 Finland
Other preterm infants
2.9
6.3
37
133
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
6.3
71
355
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
8.1
6.3
13
16
N03AF02
ATC
oxcarbazepine; oral
3.3
6.2
29
89
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
6.2
47
195
RL710
NOMESCO Finland
NA
+∞
6.2
6
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
6.2
6
*
RL720
NOMESCO Finland
NA
+∞
6.2
6
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
26.5
6.2
8
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.8
6.2
19
40
EMB30
NOMESCO Finland
Adenotomy
1.8
6.1
103
600
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.1
6.1
22
54
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.6
6.1
26
74
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.9
6.1
35
122
Q38.1
ICD-10 Finland
Ankyloglossia
3.8
6.1
24
64
P05.1
ICD-10 Finland
Small for gestational age
6.3
6.1
15
24
N29
ICPC
Neurological sympt/complt other
6.3
6.1
15
24
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
12.5
6.0
10
8
RS140
NOMESCO Finland
NA
8.6
6.0
12
14

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
329
1945
2.43
25.35
15.4
11.3
mmol/l
1.2
1.2
1.20
309
1783
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
318
1856
2.42
25.16
17.4
12.4
mmol/l
1.2
1.2
1.64
309
1763
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
377
2437
2.35
22.73
7.2
5.9
u/l
124.2
113.5
1.55
358
2297
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
277
1610
2.26
21.04
4.7
3.4
nmol/l
68.6
67.4
0.33
264
1524
(3014111) Lactate [Moles/volume] in Serum or Plasma
104
389
2.96
20.09
14.2
16.7
mmol/l
1.3
1.4
0.29
95
355
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
29
41
7.24
19.19
14.6
17.2
nmol/l
18725.7
685.0
0.49
29
41
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
29
41
7.24
19.19
18.9
24.6
nmol/l
1332.7
1330.1
0.00
29
41
(3024561) Albumin [Mass/volume] in Serum or Plasma
223
1296
2.08
15.90
9.3
8.5
g/l
37.9
38.2
0.30
211
1243
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
919
2.20
15.90
3.1
2.9
mmol/l
2.4
2.4
1.09
160
838
(40758558) Short blood count panel - Blood
251
1525
2.04
15.84
9.5
9.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
19
20
9.59
15.82
1.1
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
507
4032
2.36
14.66
20.4
11.4
mmol/l
139.6
139.4
1.36
496
3907
(3018418) pH of Serum or Plasma
154
805
2.17
14.25
4.4
4.4
ph
7.4
7.4
1.23
16
139
(3003458) Phosphate [Moles/volume] in Serum or Plasma
162
864
2.14
14.24
13.6
11.1
mmol/l
1.3
1.3
0.14
154
823
(3023103) Potassium [Moles/volume] in Serum or Plasma
506
4038
2.33
14.22
20.2
11.4
mmol/l
4.0
3.9
1.04
494
3888
(3052851) Hemolysis interference index of Serum or Plasma
48
139
3.59
13.99
2.5
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
241
1498
1.95
13.81
8.7
7.9
umol/l
21.3
18.7
0.40
226
1388
(3013336) Amino acids [Identifier] in Serum or Plasma
22
34
6.55
13.40
3.4
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
427
3245
1.96
12.94
4.5
3.4
pmol/l
14.6
14.5
0.57
396
2954
(3000991) Gas panel - Venous blood
157
858
2.07
12.79
14.8
11.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
376
2772
1.86
12.13
11.3
9.9
e9/l
0.2
0.2
0.25
341
2354
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
467
3704
2.00
11.91
4.9
3.8
mu/l
2.0
1.9
1.11
442
3490
(3006315) Basophils [#/volume] in Blood
367
2695
1.84
11.88
10.0
9.2
e9/l
0.0
0.0
0.06
325
2242
(3010015) Selenium [Moles/volume] in Serum or Plasma
18
26
6.97
11.63
3.7
3.2
umol/l
1.2
1.1
0.85
18
26
(3044889) 12 lead EKG panel
261
1741
1.82
11.47
2.9
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
365
2697
1.81
11.35
10.0
9.1
e9/l
0.6
0.6
1.07
323
2243
(3013826) Glucose [Moles/volume] in Serum or Plasma
320
2275
1.80
11.32
10.7
7.4
mmol/l
5.9
6.2
1.83
304
2088
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
200
1236
1.87
11.18
4.8
4.8
u/l
40.8
34.3
0.49
195
1177
(3002032) Base excess in Venous blood by calculation
164
950
1.95
11.16
8.6
9.8
mmol/l
0.8
1.2
1.02
133
752
(3012095) Magnesium [Moles/volume] in Serum or Plasma
114
579
2.15
11.13
15.4
12.7
mmol/l
0.8
0.8
0.39
108
551
(3003396) Base excess in Arterial blood by calculation
61
234
2.73
11.07
19.6
17.2
mmol/l
-0.4
0.0
0.24
49
193
(3013650) Neutrophils [#/volume] in Blood by Automated count
390
2957
1.81
10.95
14.3
11.1
e9/l
3.6
3.6
0.20
344
2468
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
147
826
1.98
10.90
1.8
1.5
pmol/l
98.4
99.4
0.08
70
430
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
524
4388
2.20
10.74
11.7
8.4
u/l
32.8
27.7
1.82
511
4240
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
141
792
1.97
10.42
4.1
3.6
e6/l
4.5
1.9
1.90
86
450
(3009214) Lutropin [Units/volume] in Serum or Plasma
81
371
2.32
10.12
2.8
2.2
u/l
4.6
5.5
0.93
60
244
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
15
21
7.16
9.94
4.6
2.4
umol/l
26.7
27.9
0.12
15
21
(42870588) Differential panel, method unspecified - Blood
290
2061
1.72
9.78
9.3
9.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
333
2472
1.71
9.46
4.5
3.1
mmol/mol
36.5
36.4
0.10
322
2359
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
103
536
2.07
9.35
5.6
7.3
umol/l
6.0
7.0
0.29
89
439
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
366
2793
1.71
9.34
3.8
2.2
mmol/l
5.7
5.4
3.18
343
2565
(3019198) Lymphocytes [#/volume] in Blood
369
2824
1.71
9.30
10.1
8.9
e9/l
2.3
2.3
0.11
336
2424
(3045414) Leukocytes [Presence] in Urine
40
137
3.00
8.93
1.8
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
150
901
1.84
8.90
3.2
2.9
kg/l
1.0
1.0
0.06
27
143
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
21
6.67
8.72
2.1
1.5
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
12
15
7.99
8.69
1.4
1.5
umol/l
108.9
111.1
0.03
12
15
(3009508) Creatinine [Moles/volume] in Urine
170
1074
1.77
8.48
4.2
4.8
mmol/l
7.9
8.9
1.13
150
1002
(3023323) Follitropin [Units/volume] in Serum or Plasma
69
319
2.27
8.42
2.9
2.2
iu/l
6.0
6.4
0.19
51
205
(3022096) Basophils/100 leukocytes in Blood
337
2558
1.65
8.40
10.4
9.4
%
0.6
0.6
0.82
324
2454
(3017446) Testosterone [Moles/volume] in Serum or Plasma
79
387
2.15
8.37
2.6
2.2
nmol/l
9.5
11.8
1.04
65
319
(3006504) Eosinophils/100 leukocytes in Blood
342
2625
1.63
7.99
10.4
9.2
%
3.1
3.3
0.84
329
2507
(3022313) Gas panel - Capillary blood
134
802
1.82
7.96
15.6
7.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
160
1013
1.74
7.84
3.7
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
782
1.82
7.84
4.2
3.5
e6/l
0.5
0.7
0.84
75
432
(3022948) Iron [Moles/volume] in Serum or Plasma
104
579
1.92
7.74
3.8
3.0
umol/l
12.9
14.2
0.97
95
559
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
24
5.84
7.69
2.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
373
2.11
7.63
14.1
6.8
ng/l
868.1
1065.6
0.18
58
301
(3019069) Monocytes/100 leukocytes in Blood
342
2651
1.60
7.46
11.0
9.3
%
8.3
8.3
0.06
330
2540
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
211
1455
1.65
7.46
5.8
4.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
144
897
1.75
7.43
17.2
8.1
kpa
5.0
5.0
0.13
139
865
(3021960) Folate [Moles/volume] in Serum or Plasma
88
469
1.98
7.42
1.4
1.3
nmol/l
20.2
19.0
0.33
81
421
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
143
894
1.74
7.27
17.2
8.0
mmol/l
0.4
1.0
1.46
106
641
(3004789) Transferrin [Mass/volume] in Serum or Plasma
97
539
1.91
7.24
3.8
2.9
g/l
2.6
2.6
0.09
86
519
(3044640) Blood type and Crossmatch panel - Blood
173
1145
1.67
7.12
3.6
3.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
351
2769
1.57
6.86
3.6
2.5
mmol/l
1.3
1.1
3.10
335
2636
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
370
2960
1.57
6.76
3.9
2.6
mmol/l
4.3
4.4
1.79
354
2822
(3018010) Neutrophils/100 leukocytes in Blood
347
2743
1.56
6.62
10.2
8.8
%
51.1
49.9
0.94
335
2637
(3002385) Erythrocyte distribution width [Ratio]
515
4486
1.80
6.56
22.9
14.2
%
13.3
13.1
5.19
507
4413
(3030981) Hyaline casts [#/volume] in Urine by Automated count
38
153
2.53
6.30
2.6
3.7
e6/l
0.1
0.3
0.68
38
147
(3002582) Erythrocytes [#/volume] in Urine
195
1366
1.59
6.27
5.6
4.1
e6/l
11.0
43.6
3.80
153
1045
(3002030) Lymphocytes/100 leukocytes in Blood
350
2794
1.54
6.23
10.5
8.9
%
34.0
35.0
0.88
338
2685
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
146
955
1.66
6.19
3.4
3.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
125
2.68
6.18
3.3
3.1
%
11.1
10.2
0.19
28
115
(1175426) CD3 cells/100 lymphocytes in Blood
33
125
2.68
6.18
3.3
3.1
%
65.1
66.6
0.14
33
125
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
364
2937
1.53
6.11
3.8
2.6
mmol/l
2.7
2.7
0.25
350
2764
(3018095) Leukocytes [#/volume] in Urine
223
1622
1.55
6.04
6.7
4.8
e6/l
34.2
56.3
0.70
161
1088
(3035637) Corticotropin [Mass/volume] in Plasma
42
181
2.37
6.04
1.8
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
502
1.84
6.03
4.2
3.0
%
19.7
23.0
1.64
83
477
(3007853) Bacteria identified in Skin by Aerobe culture
100
595
1.78
5.97
2.1
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
33
129
2.60
5.82
3.4
3.1
e9/l
1.7
1.5
0.36
23
81
(3026008) Bacteria identified in Urine by Culture
132
854
1.66
5.81
3.1
2.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
40
172
2.37
5.79
26.3
19.6
%
92.4
95.4
0.64
40
172
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
741
1.68
5.57
1.8
1.8
mmol/l
1.6
1.3
1.59
108
677
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
89
526
1.77
5.42
5.1
3.3
ng/l
759.9
1263.1
0.65
56
279
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
39
171
2.32
5.41
26.8
19.7
%
0.6
0.7
1.73
39
171
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
114
723
1.67
5.39
6.4
4.7
mg/l
1.2
1.6
0.54
85
483
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
358
2922
1.49
5.37
3.7
2.5
mmol/l
1.2
1.4
9.85
345
2769
(3018677) aPTT in Platelet poor plasma by Coagulation assay
108
676
1.69
5.37
9.1
7.3
s
31.0
31.1
0.05
108
669
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
147
2.42
5.34
26.7
22.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
31
123
2.55
5.32
3.2
3.0
e6/l
657.8
535.8
0.46
24
80
(3028626) Oxygen [Partial pressure] in Capillary blood
126
823
1.63
5.31
16.9
7.9
kpa
9.7
9.8
0.29
120
797
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
31
124
2.53
5.24
3.2
3.0
e9/l
0.3
0.2
0.54
24
82
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
84
2.88
5.22
26.0
29.7
u/ml
0.3
0.3
0.27
15
52
(3026782) Osmolality of Urine
133
884
1.61
5.22
4.6
3.2
mosm/kgh2o
597.3
605.2
0.12
120
780
(3019060) Gas panel - Arterial blood
23
79
2.93
5.17
6.5
9.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
336
2723
1.47
5.12
8.9
6.3
ml/min/173m2
113.8
110.4
2.04
229
1909
(3021589) Normoblasts [#/volume] in Blood
320
2572
1.46
5.07
10.2
10.6
e9/l
0.0
0.0
0.50
255
1965
(3030467) Casts [#/volume] in Urine by Automated count
177
1269
1.52
4.95
5.7
4.0
e6/l
0.2
0.2
0.34
132
952
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
124
2.45
4.76
3.4
3.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
45
223
2.06
4.66
5.4
15.1
g/l
132.4
128.6
0.51
45
217
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
28
115
2.46
4.51
3.4
3.0
%
20.9
25.9
1.38
28
115
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
140
2.31
4.50
14.7
10.6
mmol/l
22.3
23.3
1.18
32
127
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
8
9.92
4.47
1.8
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
176
1286
1.48
4.43
5.7
3.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
111
734
1.59
4.41
4.4
4.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
525
4723
1.64
4.39
13.4
7.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
84
522
1.67
4.27
1.5
1.5
u/ml
227.9
466.2
1.15
78
498
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
384
1.77
4.25
2.4
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
211
1611
1.44
4.18
5.4
4.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
72
2.78
4.17
2.9
4.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
70
417
1.73
4.15
2.1
1.9
g/l
1.0
0.9
0.45
65
395
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
477
5057
0.66
4.07
3.7
3.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
303
2475
1.40
4.05
5.4
3.7
e6/l
163.4
174.1
—
10
24
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
382
1.75
4.05
2.7
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
79
2.67
4.04
2.1
1.9
—
—
—
0
0
(4034850)
19
68
2.80
4.01
14.4
5.0
—
—
—
0
0
(3015736) pH of Urine
201
1531
1.43
4.01
3.8
3.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
29
129
2.27
3.95
3.6
3.4
%
21.8
16.7
0.60
29
129
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
210
1.98
3.91
4.7
3.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
99
658
1.57
3.84
2.2
1.7
%
1.7
1.4
0.64
92
606
(3027273) Bicarbonate [Moles/volume] in Venous blood
31
144
2.17
3.82
5.1
7.7
mmol/l
24.2
24.2
0.04
31
135
(3000850) Epithelial cells [#/volume] in Urine
128
902
1.50
3.80
4.5
3.2
e6/l
6.9
6.5
0.11
113
800
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
34
165
2.08
3.75
2.4
4.7
mg/l
274.4
343.7
0.97
34
159
(3051651) Icteric interference index of Serum or Plasma
18
65
2.77
3.75
2.9
4.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
584
5461
2.08
3.66
25.0
14.8
e9/l
266.9
265.7
0.16
567
5225
(3019225) pH of Specimen
34
167
2.06
3.64
4.7
4.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
128
911
1.48
3.61
9.2
4.0
inr
1.1
1.1
0.00
25
275
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
175
2.02
3.58
1.7
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
584
5471
2.04
3.47
24.9
14.6
pg
29.0
29.1
1.06
578
5398
(3026361) Erythrocytes [#/volume] in Blood
584
5471
2.04
3.47
24.9
14.7
e12/l
4.7
4.7
1.03
563
5221
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
98
2.35
3.47
2.5
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
31
3.53
3.39
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
505
0.48
3.38
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
584
5476
2.02
3.38
25.0
14.7
e9/l
7.0
6.9
0.46
564
5231
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
237
0.32
3.38
1.5
1.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
27
125
2.17
3.37
3.4
3.1
e6/l
525.0
315.9
0.86
20
75
(3027945) Reticulocytes/100 erythrocytes in Blood
85
562
1.56
3.37
7.2
7.1
%
1.5
1.4
0.37
79
543
(3009871) Measles virus Ab [Titer] in Serum
8
14
5.67
3.30
1.8
2.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
583
5470
1.97
3.26
24.9
14.6
fl
86.3
86.5
0.47
577
5396
(44790049)
25
114
2.20
3.25
3.2
2.4
—
—
—
0
0
(44790048)
25
114
2.20
3.25
3.2
2.4
—
—
—
0
0
(44790047)
25
114
2.20
3.25
3.2
2.4
—
—
—
0
0
(44806118)
25
114
2.20
3.25
3.2
2.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
161
2.00
3.24
2.6
5.0
e6/l
35.9
421.3
0.88
26
111
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
161
2.00
3.24
2.5
5.0
e6/l
9.2
4.9
0.24
24
108
(40761535) Cells panel - Urine sediment
33
168
1.98
3.24
3.2
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
188
2274
0.73
3.23
2.0
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
60
368
1.67
3.23
2.1
2.8
u/l
23.0
32.1
2.64
49
304
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
19
4.70
3.19
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
43
3.01
3.16
5.2
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
34
177
1.94
3.14
2.1
2.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
224
0.34
3.12
1.4
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
26
123
2.12
3.10
1.7
1.5
ug/l
5.8
8.2
0.45
26
117
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
91
2.31
3.07
2.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
61
2.62
3.04
3.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
118
2.13
3.00
2.6
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
152
1.99
3.00
3.9
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
52
314
1.68
2.98
2.7
2.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
139
2.02
2.96
2.1
3.1
ml/min/173m2
85.2
95.9
—
7
41
(3000494) Fungus identified in Specimen by Culture
61
385
1.62
2.95
1.5
1.9
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
31
160
1.95
2.94
2.3
4.8
mmol/l
3.3
3.4
0.44
31
153
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
13
45
2.87
2.94
2.2
1.6
nmol/l
20.8
20.2
—
5
13
(3045424) Erythrocytes [Presence] in Urine
14
51
2.73
2.90
1.4
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
42
241
1.76
2.88
1.5
1.6
nmol/l
990.6
1112.3
0.38
32
190
(3034426) Prothrombin time (PT)
8
17
4.66
2.88
1.4
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
320
2728
1.32
2.87
5.6
3.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
78
1080
0.67
2.85
2.1
1.9
—
—
—
0
0
(3020891) Body temperature
19
82
2.31
2.82
6.7
8.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
20
89
2.25
2.77
5.7
6.0
ug/l
2.6
1.9
0.58
20
89
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
52
321
1.64
2.76
2.4
2.1
mmol/l
2.4
2.4
0.03
40
275
(3035350) Ketones [Presence] in Urine by Test strip
233
1909
1.32
2.74
4.0
3.2
estimate
0.0
0.0
0.00
20
350
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
523
1.51
2.72
2.6
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
111
1427
0.71
2.69
1.8
1.8
—
—
—
0
0
(3032641) Amino acids panel - Urine
7
14
4.95
2.69
1.0
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
239
1.73
2.68
5.9
9.2
g/l
0.2
0.4
1.13
26
197
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
111
2.07
2.63
2.7
2.1
—
—
—
0
0
(4306422)
15
60
2.49
2.61
1.1
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
37
2.95
2.61
8.4
7.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
105
2.10
2.59
3.2
2.0
—
—
—
0
0
(4268621)
12
43
2.77
2.57
2.7
2.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
147
1.91
2.56
3.5
2.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
25
3.57
2.53
3.1
6.2
ug/l
167.6
223.2
—
9
25
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
297
2535
1.29
2.52
5.0
4.0
u/l
35.5
28.0
1.67
290
2435
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
511
4700
1.41
2.52
15.9
10.2
mg/l
22.5
22.7
0.03
388
3199
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
19
87
2.18
2.48
4.0
4.8
umol/l
23.9
24.8
0.17
19
87
(4198724)
19
87
2.18
2.48
2.7
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
230
1906
1.30
2.43
5.7
4.7
estimate
0.0
0.0
0.00
25
374
(4010399)
38
224
1.71
2.41
1.3
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
6
12
4.94
2.37
2.7
3.5
%
9.2
8.0
—
6
12
(21494814) CD8 cells/100 lymphocytes in Specimen
6
12
4.94
2.37
2.7
3.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
104
2.02
2.27
1.5
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
18
3.85
2.21
2.0
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
248
0.42
2.19
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
138
1669
0.76
2.19
2.4
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
185
1.74
2.19
1.5
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
19
92
2.06
2.19
2.9
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
229
1918
1.27
2.18
4.1
3.3
estimate
0.0
0.0
0.00
25
364
(3013512) EKG study
73
515
1.44
2.16
3.0
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
48
310
1.56
2.16
2.3
1.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
24
3.30
2.14
3.4
3.7
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
32
187
1.72
2.12
3.8
2.9
mu/l
14.5
20.8
0.78
32
179
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
42
2.60
2.11
1.5
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
384
0.55
2.11
1.1
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
9
30
2.97
2.10
1.4
1.2
mu/l
651.3
378.7
—
9
30
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
9
30
2.97
2.10
1.4
1.2
%
72.7
75.9
—
9
30
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
14
61
2.28
2.07
17.2
11.0
mg/l
9.6
8.5
0.22
14
56
(3023520) Reticulocytes [#/volume] in Blood
60
411
1.48
2.07
4.6
5.0
e9/l
73.6
61.5
1.23
47
241
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
43
2.54
2.03
2.5
4.2
ug/l
18.2
25.3
1.48
11
43
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
102
1.96
2.02
1.6
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
20
3.46
2.02
4.6
2.5
umol/l
13.0
14.3
—
7
20
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
315
0.52
1.99
1.7
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
122
951
1.32
1.99
3.7
3.4
estimate
0.0
0.0
0.50
25
354
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
90
670
1.37
1.98
3.1
2.2
ng/l
74.5
71.0
0.02
45
234
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
50
2.38
1.96
1.5
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
44
2.48
1.94
2.2
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
68
485
1.42
1.92
2.5
2.8
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
16
3.71
1.90
3.2
3.3
e9/l
0.2
0.2
—
6
16
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
33
2.70
1.89
27.1
5.9
mmol/l
1.2
1.2
—
9
26
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
138
1103
1.29
1.87
3.8
3.3
mg/l
2.8
2.6
0.63
126
985
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
273
1.55
1.86
2.0
1.9
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
11
45
2.42
1.86
5.5
7.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
11
45
2.42
1.86
6.4
7.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
523
0.64
1.86
1.4
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
65
2.14
1.81
1.6
1.2
u/ml
9.0
3.9
—
8
30
(3026250) Tacrolimus [Mass/volume] in Blood
14
65
2.14
1.81
62.7
43.5
ug/l
6.7
6.5
0.20
14
60
(3017509) Phencyclidine [Presence] in Urine
5
12
4.11
1.79
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
151
1.72
1.79
2.8
5.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
46
2.37
1.79
3.1
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
328
0.55
1.78
6.8
3.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
408
1.44
1.77
1.6
1.3
iu/ml
137.8
126.5
0.06
12
139
(3013707) Erythrocyte sedimentation rate by Westergren method
324
2871
1.23
1.76
5.1
4.2
mm/h
8.1
7.1
0.90
307
2662
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
101
1.87
1.73
2.7
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
238
1.56
1.73
1.5
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
510
4758
1.31
1.73
23.8
13.4
g/l
335.3
335.9
0.66
504
4711
(3024928) Oxygen saturation in Venous blood
22
123
1.78
1.72
5.0
20.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
80
1012
0.74
1.72
1.8
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
18
3.29
1.71
2.3
2.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
47
2.32
1.71
1.5
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
109
1.83
1.70
1.4
1.4
ug/g
328.1
384.9
0.74
15
54
(3016018) Differential panel - Cerebral spinal fluid
19
102
1.85
1.69
2.8
4.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
13
3.80
1.69
4.2
3.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
13
3.80
1.69
1.0
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
74
2.01
1.68
2.5
1.8
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
17
88
1.92
1.68
3.9
2.4
mmol/l
1.5
2.2
—
10
70
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
54
2.20
1.67
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
89
1.90
1.63
4.8
6.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
62
2.08
1.59
4.5
6.1
—
—
—
0
0
(4146454)
5
14
3.52
1.59
2.6
2.8
—
—
—
0
0
(4035726)
32
204
1.57
1.57
2.4
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
214
1835
1.22
1.56
1.9
1.6
g/l
1.7
1.7
0.06
112
976
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
57
2.09
1.49
1.1
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
52
372
1.41
1.48
9.2
6.9
u/l
252.3
289.8
0.86
52
364
(3012516) Albumin [Mass/volume] in Urine
58
423
1.38
1.48
3.6
3.9
mg/l
1179.3
131.0
0.45
44
331
(4027681)
10
44
2.25
1.47
1.1
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
37
2.41
1.47
1.0
1.1
mg/l
262.9
311.8
—
9
32
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
130
1.69
1.46
2.2
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
135
1565
0.80
1.46
2.7
2.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
51
2.14
1.45
9.6
9.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
51
2.14
1.45
3.2
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
482
0.67
1.44
1.5
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
123
1.70
1.44
3.1
6.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
58
426
1.37
1.42
3.8
4.6
mg/mmol
4.9
16.9
1.56
40
337
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
282
0.58
1.42
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
45
2.20
1.41
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
73
557
1.32
1.40
2.5
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
45
320
1.41
1.34
1.6
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
23
2.58
1.34
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
89
1.78
1.31
7.1
7.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
33
2.40
1.30
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
151
1.58
1.28
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
151
1.58
1.28
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
24
2.47
1.27
2.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
54
2.02
1.27
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.26
1.25
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
35
2.26
1.25
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
35
2.26
1.25
2.0
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
39
274
1.42
1.25
7.6
5.6
%
0.8
0.6
0.28
13
85
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
98
1.72
1.25
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
176
1.53
1.24
1.4
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
244
2157
1.18
1.24
3.9
3.1
ug/l
65.0
59.6
0.27
236
2043
(40768804) Tissue Pathology biopsy report
117
965
1.23
1.23
1.9
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
36
2.20
1.22
2.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
43
309
1.39
1.22
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
128
1464
0.82
1.20
2.4
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
77
1.80
1.19
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
163
1.53
1.16
1.5
1.1
—
—
—
0
0
(4094501)
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
20
2.46
1.13
1.0
1.8
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
20
2.46
1.13
1.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
40
1.98
1.10
3.4
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
155
1330
1.19
1.09
3.4
3.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
189
0.56
1.08
1.4
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
21
2.35
1.07
1.2
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
188
0.57
1.06
1.4
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
115
963
1.21
1.05
5.7
5.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
524
4979
1.23
1.01
22.6
13.1
%
40.1
40.1
0.00
460
4458
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
208
0.60
0.99
1.0
1.1
—
7.2
—
0
33
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
220
1.40
0.98
3.2
1.9
%
30.3
31.8
0.27
21
165
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.28
0.94
1.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
26
2.28
0.94
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.28
0.94
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
27
2.19
0.92
1.0
2.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
37
1.87
0.92
5.3
5.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
20
132
1.50
0.91
1.6
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
101
0.48
0.90
4.6
4.3
e9/l
2.4
3.2
—
5
101
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
93
1.60
0.88
3.1
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
55
1.80
0.88
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
10
55
1.80
0.88
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
278
1.33
0.85
2.6
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
109
0.54
0.84
1.7
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
79
1.63
0.83
3.1
3.7
%
17.5
18.4
—
7
51
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
103
1.54
0.82
3.6
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
636
0.80
0.81
2.5
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
255
1.33
0.80
5.3
4.9
%
0.7
0.4
—
10
61
(3012501) Base excess in Blood by calculation
13
80
1.61
0.80
8.1
8.0
mmol/l
1.5
2.0
—
6
46
(40768795) Lymph node Pathology biopsy report
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
252
0.69
0.78
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
33
1.79
0.77
1.2
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
23
2.14
0.75
1.0
2.3
g/l
0.0
0.0
—
5
23
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
23
2.14
0.75
1.0
2.3
g/l
0.0
0.0
—
5
23
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
24
2.05
0.74
1.0
2.2
g/l
40.5
41.1
—
5
24
(4062490)
14
90
1.54
0.73
1.6
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
123
1.45
0.72
1.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
25
1.97
0.72
2.8
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
173
1547
1.14
0.71
1.6
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
99
1.50
0.71
1.7
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
7
40
1.73
0.70
1.1
6.5
—
140.3
—
0
22
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
26
1.89
0.69
1.0
2.2
g/l
0.0
0.0
—
5
26
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
26
1.89
0.69
1.0
2.2
g/l
0.0
0.2
—
5
26
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
334
0.75
0.69
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
34
262
1.29
0.68
7.8
5.7
%
0.1
0.0
0.29
12
79
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
271
1.28
0.68
2.8
2.1
—
93.3
—
0
25
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
27
1.82
0.67
1.0
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
109
1.45
0.66
2.4
1.9
iu/l
2.4
5.4
—
6
38
(3022670) pH of Venous cord blood
5
28
1.76
0.65
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
150
0.65
0.63
1.7
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
102
0.57
0.62
7.7
4.6
%
42.8
50.0
—
6
102
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
34
267
1.26
0.60
1.1
1.2
—
31.0
—
0
8
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
19
0.00
0.60
0.0
1.0
—
—
—
0
0
(4211845)
0
19
0.00
0.60
0.0
2.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
52
1.52
0.58
1.8
2.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
36
1.64
0.56
5.8
5.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
55
461
1.19
0.55
2.8
2.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
73
1.49
0.52
3.1
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
350
0.80
0.51
1.2
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
32
257
1.23
0.49
8.1
5.7
%
0.0
0.0
0.74
11
72
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
230
0.76
0.49
3.2
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
348
0.81
0.49
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
222
1.25
0.48
2.4
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
211
1949
1.10
0.48
1.5
1.8
u/ml
0.4
4.1
7.00
39
359
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
46
1.50
0.48
2.1
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
823
1.13
0.47
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
48
1.44
0.46
1.3
1.6
mmol/l
8.4
6.6
—
7
31
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
35
288
1.20
0.44
1.9
2.2
—
16.2
—
0
20
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
463
1.16
0.43
2.7
2.6
u/l
7591.8
4381.5
0.22
13
171
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
30
1.64
0.43
1.0
1.0
miu/ml
2497.4
1702.3
—
5
30
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
181
0.75
0.43
1.9
1.5
iu/ml
0.0
0.1
—
7
49
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
226
1.23
0.43
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
111
1.33
0.42
1.8
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
55
1.43
0.42
3.6
2.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
55
1.43
0.42
1.8
1.8
mu/l
44.4
278.9
—
8
50
(3042517) Benzodiazepines panel - Urine
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
33
1.49
0.41
1.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
17
0.00
0.40
0.0
3.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
56
485
1.15
0.40
1.5
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
34
1.45
0.39
1.6
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
8
60
1.31
0.39
6.0
4.4
%
1.0
0.9
—
8
48
(40765089) Chromosome analysis panel - Blood by G-banded
8
60
1.31
0.39
1.3
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
70
1.41
0.38
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
122
1.29
0.38
2.8
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
66
1.34
0.38
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
110
0.71
0.37
1.1
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
105
1.32
0.37
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
249
1.19
0.36
1.4
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
75
0.65
0.36
9.0
2.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
77
0.63
0.36
1.6
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
120
0.73
0.35
1.7
1.8
—
—
—
0
0
(1002224) Polysomnography panel
14
106
1.30
0.35
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
42
1.41
0.35
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
42
1.41
0.35
1.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
43
1.37
0.34
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
19
151
1.24
0.34
1.4
1.9
—
59.3
—
0
15
(42870560) Thyrotropin [Units/volume] in Cord blood
21
169
1.23
0.34
1.0
1.0
mu/l
10.2
9.4
0.22
15
137
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
44
1.34
0.34
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
478
0.87
0.34
1.2
1.2
iu/ml
13.8
15.6
—
8
105
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
205
0.81
0.32
2.1
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
844
1.10
0.32
1.7
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
76
683
1.11
0.32
2.5
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
53
1.30
0.30
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
203
0.82
0.30
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
463
0.88
0.30
1.2
1.2
u/ml
0.9
5.2
1.88
14
141
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
106
0.74
0.29
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
95
998
0.92
0.28
3.5
2.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
18
146
1.22
0.28
1.3
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
117
0.75
0.27
1.0
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
64
1.23
0.27
1.3
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
70
0.70
0.26
1.8
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
71
0.69
0.26
1.0
1.4
—
—
—
0
0
(44813793)
11
85
1.27
0.25
1.0
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
82
0.72
0.24
1.2
1.5
—
290.0
—
0
5
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
37
1.33
0.23
1.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
37
1.33
0.23
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
37
1.33
0.23
1.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
104
1.23
0.23
1.5
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
186
0.84
0.23
1.4
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
89
0.77
0.22
1.0
1.3
—
7.7
—
0
12
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
90
0.76
0.22
1.0
1.4
—
40.3
—
0
15
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
39
1.26
0.22
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
39
1.26
0.22
1.0
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
40
1.23
0.22
2.4
3.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
153
0.83
0.21
1.6
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
42
1.17
0.21
1.4
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
318
0.89
0.21
1.4
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.20
0.0
1.3
—
10.4
—
0
13
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.20
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
204
0.86
0.20
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
779
0.94
0.18
2.1
2.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
57
1.21
0.18
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
89
1.22
0.18
6.7
25.8
%
14.0
11.9
1.34
11
89
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
150
0.85
0.18
1.6
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
342
1.10
0.18
2.7
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
79
734
1.06
0.18
2.5
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
304
0.90
0.17
1.7
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
78
725
1.06
0.17
2.5
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
99
1017
0.95
0.17
3.3
3.4
ug/g
88.9
120.8
0.79
78
810
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
1216
0.95
0.17
1.9
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
220
1.12
0.17
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
78
726
1.06
0.17
2.5
2.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
258
1.11
0.17
1.4
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
99
1.19
0.17
3.3
4.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
180
0.87
0.16
1.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
79
736
1.06
0.16
2.5
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
118
1.17
0.16
3.6
4.8
u/ml
3.8
19.3
0.98
14
111
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
6
74
0.79
0.15
1.3
1.9
mmol/l
8.3
7.0
—
6
48
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
75
0.78
0.15
1.0
1.4
—
1.6
—
0
8
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
77
0.76
0.15
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
65
604
1.06
0.15
1.4
1.5
titre
980.0
612.9
—
8
87
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
422
1.08
0.15
1.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
166
1.13
0.14
1.2
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
8
94
0.83
0.14
1.0
1.3
—
42.0
—
0
7
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
37
338
1.08
0.13
2.8
1.9
u/ml
165.2
154.8
0.08
20
170
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
146
0.87
0.13
1.6
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
89
907
0.96
0.12
2.5
2.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
41
427
0.94
0.11
1.1
1.2
u/ml
4.6
7.8
0.79
27
330
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
235
0.92
0.11
1.5
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
67
631
1.05
0.10
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
44
1.12
0.10
1.4
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
44
1.12
0.10
1.4
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
95
1.14
0.09
1.9
2.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
172
0.91
0.09
1.3
1.5
u/ml
24.7
10.8
0.24
11
116
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
55
1.07
0.08
1.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
222
0.93
0.08
1.0
1.1
u/ml
0.9
0.4
—
9
103
(3008401) Mugwort IgE Ab [Units/volume] in Serum
41
422
0.95
0.08
1.1
1.2
u/ml
1.7
1.3
0.18
27
307
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
412
0.95
0.08
1.1
1.2
u/ml
3.9
4.4
0.07
14
134
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
230
1.07
0.08
1.1
1.1
u/ml
4.1
11.3
1.26
12
146
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
110
0.89
0.07
1.3
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
19
173
1.08
0.07
1.2
1.4
u/ml
2.0
3.1
0.39
13
119
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
12
130
0.90
0.07
1.2
1.4
u/ml
52.4
14.0
—
7
107
(40768443) Skin Pathology biopsy report
11
97
1.11
0.06
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
126
1.09
0.06
5.2
2.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
147
1.07
0.04
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
273
1.04
0.04
1.5
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
61
585
1.03
0.04
1.2
1.3
—
203.9
—
0
26
(3005033) Fetal Nuchal fold Thickness US
15
157
0.94
0.04
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
157
0.94
0.04
1.5
1.5
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
13
136
0.94
0.03
1.0
1.0
kpa
6.7
7.3
—
7
107
(3006598) pH of Arterial cord blood
13
136
0.94
0.03
1.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
13
134
0.95
0.01
1.0
1.0
kpa
3.5
3.3
—
7
105
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
46
458
0.98
0.01
1.2
1.3
u/ml
3.4
2.0
0.31
28
299
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
161
1.04
0.00
1.5
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
133
0.96
0.00
1.1
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
202
1.02
0.00
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
202
1.02
0.00
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
202
1.02
0.00
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
202
1.02
0.00
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
11
103
1.05
0.00
2.7
3.2
g/l
134.2
139.2
0.37
11
85
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
271
1.01
0.00
1.4
1.3
miu/ml
330.1
249.2
0.41
11
136
(3000492) Spirometry study
38
373
1.00
0.00
1.7
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
252
1.01
0.00
1.2
1.1
u/ml
3.7
9.0
1.34
14
145
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
261.2
—
0
5
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
37.0
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
20.6
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.8
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.9
—
3.0
—
0
8
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
64
0.92
0.00
1.5
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.6
—
1.5
—
0
9
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
66
0.89
0.00
14.5
9.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
62
0.95
0.00
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
49
1.00
0.00
3.2
2.4
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
55
0.89
0.00
1.0
1.0
g/l
175.6
162.4
—
5
55
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
59
1.00
0.00
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
60
0.98
0.00
1.3
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
57
0.86
0.00
1.4
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_MOTOR – Specific developmental disorder of motor function

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).